Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2025.111935DOI Listing

Publication Analysis

Top Keywords

it's time
4
time update
4
update agree
4
agree iii
4
iii iteration
4
iteration guideline
4
guideline appraisal
4
it's
1
update
1
agree
1

Similar Publications

Kinematic alignment is increasingly adopted in total knee arthroplasty (TKA) as a patient-specific strategy to restore native joint anatomy. However, its reliance on static radiographic measurements may not adequately reflect real-world functional biomechanics. This editorial underscores the importance of complementing static assessment with kinetic principles.

View Article and Find Full Text PDF

Background: Medical education has been experiencing a transition from time- to competency-based. Since their introduction by Olle ten Cate in 2005, entrustable professional activities are a part of this process. We implemented a set of EPAs for the first 3 years of training at our hospital, encompassed by informational materials for trainees and supervisors.

View Article and Find Full Text PDF

The effects of climate change harms upon public health could be disastrous. Many have likened the urgency and peril associated with our global situation to living in a house on fire. This article uses the housefire metaphor to consider how public health teams and others can encourage actions that lessen climate-related harms.

View Article and Find Full Text PDF

Blinatumomab is a bispecific T-cell engager that has recently transformed front-line treatment for many patients with Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (B-ALL). It was originally studied in relapsed/refractory disease, then moved to targeting measurable residual disease (MRD), and has since been shown to improve outcomes for almost every age group when added to consolidation chemotherapy. The evidence supporting blinatumomab is most robust in adult and standard-risk pediatric age groups, but its benefit in adolescents and young adults and high-risk pediatric patients is not yet understood.

View Article and Find Full Text PDF